88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

FaceHeart Received Another FDA Clearance for its Contactless Video-Based Vital Sign Measurement of Respiratory Rate Developed by FaceHeart, FH Vitals SDK-RR has obtained FDA Clearance. This is the second 510(k) class II SaMD (Software as a Medical Device) FaceHeart received from the FDA. FaceHeart Vitals™ is a video-based, ... 2025-05-01T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis SUZHOU, China , May 1, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that a phase II/III ... 2025-05-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Preserving fertility and optimising care for the one in seven women suffering from endometriosis SINGAPORE , May 1, 2025 /PRNewswire/ -- Fertility specialists in the Asia Pacific region are bringing to fruition new standards of care for women and girls suffering from endometriosis and to help ... 2025-05-01T Health Care/Hospital Medical/Pharmaceuticals
S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial SEOUL, South Korea , May 1, 2025 /PRNewswire/ -- S&E bio Co., Ltd. , a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food ... 2025-05-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
JediCare Medical has announced successful completion of its first-in-human feasibility study of the world's first-of-its-kind Pulmonary Nodule Percutaneous Sphere Resection SHANGHAI , April 30, 2025 /PRNewswire/ -- JediCare Medical Technology Co., Ltd. a Shanghai, China based company ("the Company"), jointly with West China Hospital of Sichuan University, ... 2025-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Mabwell Releases 6 Study Results of Innovative Drugs and Platforms at the 2025 AACR Annual Meeting SHANGHAI , April 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in ... 2025-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Gedeon Richter: Medical Treatment of Endometriosis with a progressive approach PRAGUE and BUDAPEST, Hungary , April 30, 2025 /PRNewswire/ -- Modern medical treatment options for endometriosis were among the main topics at the SEUD Congress (Society of Endometriosis ... 2025-04-30T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy Genocury launched the in vivo CD19 CAR-T therapy to reach the clinical stage, demonstrating exceptional safety, efficiency and durability. ... 2025-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
J INTS BIO Presents Research Results for Next-Generation Innovative Anticancer Therapeutics 'JIN-A02' and 'JIN-001' at AACR 2025 SEOUL, South Korea , April 30, 2025 /PRNewswire/ -- J INTS BIO, a company specializing in anticancer and orphan drugs, announced its research findings for the next-generation EGFR-TKI therapeutic ... 2025-04-30T Health Care/Hospital Medical/Pharmaceuticals
Alphamab Oncology Presented Preclinical Data on Two Novel Bispecific ADCs at the 2025 AACR Annual Meeting SUZHOU, China , April 30, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 ... 2025-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2025

Suntek Computer Systems Limited.

All rights reserved